{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:28:53Z","timestamp":1791250133744,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejca.2013.09.024","type":"journal-article","created":{"date-parts":[[2013,10,21]],"date-time":"2013-10-21T13:16:20Z","timestamp":1382361380000},"page":"332-340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases"],"prefix":"10.1016","volume":"50","author":[{"given":"D.","family":"Elias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Go\u00e9r\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dumont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Honor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dartigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stoclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Malka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Boige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.09.024_b0005","first-page":"256","article-title":"Clinical delivery system for intraperitoneal hyperthermic chemotherapy","volume":"40","author":"Spratt","year":"1980","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.09.024_b0010","first-page":"66","article-title":"Rationale for perioperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy","volume":"1","author":"Sugarbaker","year":"1988","journal-title":"Reg Cancer Treat"},{"key":"10.1016\/j.ejca.2013.09.024_b0015","first-page":"3380","article-title":"Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy","volume":"49","author":"Los","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.09.024_b0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0959-8049(97)00370-5","article-title":"Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines","volume":"34","author":"van de Vaart","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.09.024_b0025","first-page":"1840","article-title":"Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug","volume":"44","author":"Koga","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.09.024_b0030","first-page":"207","article-title":"Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts","volume":"41","author":"Elias","year":"1994","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejca.2013.09.024_b0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/978-1-4613-1247-5_10","article-title":"Cancer cell seeding during abdominal surgery: experimental studies","volume":"82","author":"Zoetmulder","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejca.2013.09.024_b0040","first-page":"175","article-title":"Tumor implantation in cicatrization sites following surgery for digestive cancers","volume":"133","author":"Jacquet","year":"1996","journal-title":"J Chir (Paris)"},{"key":"10.1016\/j.ejca.2013.09.024_b0045","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S1055-3207(18)30039-5","article-title":"Intraperitoneal chemohyperthermia: rationale, technique, indications and results","volume":"10","author":"Elias","year":"2001","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejca.2013.09.024_b0050","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1245\/s10434-007-9348-1","article-title":"Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43\u00b0C after complete cytoreductive surgery: mortality and morbidity in 106 consecutive patients","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0055","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperaticve intraperitoneal chemotherapy. A multi-institutional study of 1290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.09.024_b0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/SLA.0b013e3181b5ae43","article-title":"Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment","volume":"251","author":"Chua","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0065","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early and long-term outcome data on 2298 patients with pseudomyxoma peritonei of appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0070","doi-asserted-by":"crossref","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience","volume":"27","author":"Yan","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jso.23189","article-title":"Summary of current therapeutic options for peritoneal metastases from colorectal cancer","volume":"107","author":"Chua","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0080","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1470-2045(12)70210-3","article-title":"Cytoreductive surgery plus HIPEC to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?","volume":"13","author":"Sugarbaker","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0085","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","article-title":"Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis; a clinicopathological analysis of 109 cases","volume":"19","author":"Ronnett","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2013.09.024_b0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.pas.0000202039.74837.7d","article-title":"Pseudomyxoma peritonei of appendiceal origin: a clinocopathologic analysis of 101 patients uniformly treated at a single institution","volume":"30","author":"Bradley","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejca.2013.09.024_b0095","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","article-title":"Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy","volume":"241","author":"Miner","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","article-title":"Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma","volume":"10","author":"Turner","year":"2012","journal-title":"J Nat Compr Cancer Netw"},{"key":"10.1016\/j.ejca.2013.09.024_h0105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002920050340","article-title":"Peritoneal mesothelioma incidence and aetiology","volume":"20","author":"Neumann","year":"1999","journal-title":"Pathologe"},{"key":"10.1016\/j.ejca.2013.09.024_h0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdp307","article-title":"Malignant peritoneal mesothelioma: a multicenter study on 81 cases","volume":"21","author":"de Pangher","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","article-title":"Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma","volume":"153","author":"Alexander","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.ejca.2013.09.024_b0115","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO;2-V","article-title":"Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors","volume":"63","author":"Chu","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.09.024_b0120","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O","article-title":"Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study","volume":"88","author":"Sadeghi","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.09.024_b0125","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1046\/j.1365-2168.2002.02274.x","article-title":"Peritoneal carcinomatosis from colorectal cancer","volume":"89","author":"Jayne","year":"2002","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"30","author":"Franko","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejso.2012.03.008","article-title":"Outcomes of colorectal patients with peritoneal carcinomatosis treated with chemotherapy with and without targeted therapy","volume":"38","author":"Klaver","year":"2012","journal-title":"EJSO"},{"key":"10.1016\/j.ejca.2013.09.024_b0140","first-page":"1587","article-title":"Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases","volume":"12","author":"Mulsaw","year":"2011","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0145","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1016\/S1470-2045(12)70448-5","article-title":"HIPEC: standard of care or an experimental approach?","volume":"13","author":"Evrard","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0150","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ejso.2012.03.001","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal carcinomatosis: prognosis and treatment of recurrences in a cohort study","volume":"38","author":"Cashin","year":"2012","journal-title":"EJSO"},{"key":"10.1016\/j.ejca.2013.09.024_b0155","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000320460","article-title":"Validation and clinical use of the Japanese classification of colorectal carcinomatosis. Benefit of surgical cytoreduction, even without intraperitoneal chemotherapy","volume":"27","author":"Kobayashi","year":"2010","journal-title":"Dig Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0160","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0165","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with and without irinotecan during HIPEC following cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0170","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/SLA.0b013e31827e9289","article-title":"Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?","volume":"257","author":"Goere","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0175","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/ASO.2004.12.929","article-title":"Peritoneal carcinomatosis or liver metastases from colorectal cancer: similar standards for a curative surgery?","volume":"11","author":"Elias","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0180","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1245\/s10434-008-0127-4","article-title":"Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients","volume":"15","author":"Shen","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/jso.21369","article-title":"Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastases","volume":"100","author":"Cao","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1200\/JCO.2009.23.9285","article-title":"Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study","volume":"28","author":"Elias","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0195","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/SLA.0b013e3182778089","article-title":"Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastasi be treated with a curative intent?","volume":"258","author":"Maggiori","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0200","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/SLA.0b013e31815f0113","article-title":"Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis","volume":"247","author":"Elias","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0205","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10434-004-1167-z","article-title":"Long-term survival of peritoneal carcinomatosis of colorectal origin","volume":"12","author":"Verwaal","year":"2005","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0210","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jamcollsurg.2006.08.024","article-title":"Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer","volume":"203","author":"da Silva","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0215","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1245\/s10434-012-2473-5","article-title":"Definition of patients presenting a high risk of developing peritoneal carcinomatosis after curative surgery for colorectal cancer. A systematic review","volume":"20","author":"Honor\u00e9","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0220","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/SLA.0b013e31822638f6","article-title":"Results of a systematic second-look surgery plus HIPEC in asymptomatic patients presenting a high risk of developing colorectal peritoneal carcinomatosis","volume":"254","author":"Elias","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/archsurg.139.1.20","article-title":"Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer","volume":"139","author":"Glehen","year":"2004","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0230","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/bjs.4695","article-title":"Treatement of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion","volume":"92","author":"Yonemura","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1245\/s10434-006-9205-7","article-title":"Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer","volume":"14","author":"Cheong","year":"2007","journal-title":"Ann surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0240","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","article-title":"Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy","volume":"17","author":"Glehen","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0245","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jso.21519","article-title":"Cytoreductive surgery plus hyperthermic intraperitneal chemotherapy to treat gastric cancer with ascites and\/or peritoneal carcinomatosis: results from a Chinese center","volume":"101","author":"Yang","year":"2010","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/148420","article-title":"Effects of neoadjuvant intraperitoneal\/systemic chemotherapy (bidirectional chemotherapy) for the treatment of patients with peritoneal metastasis from gastric cancer","author":"Yonemura","year":"2012","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0255","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","article-title":"Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedure on survival in advanced ovarian cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0260","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.soc.2012.07.007","article-title":"Current status and future directions of cytoreductive surgery and HIPEC in the treatment of ovarian cancer","volume":"21","author":"Helm","year":"2012","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejca.2013.09.024_b0265","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ejso.2010.11.004","article-title":"Advanced cytoreduction as surgical standard of care and HIPEC as promising treatment in epithelial ovarian cancer. Review","volume":"37","author":"Deraco","year":"2011","journal-title":"Eur J Surg Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2013.09.024_b0270","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.1200\/jco.2009.27.15_suppl.5542","article-title":"Cytoreductive surgery combined with intraperitoneal chemotherapy for the management of peritoneal chemotherapy from ovarian cancer","volume":"27s","author":"Bereder","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0275","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0280","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s00268-007-9146-8","article-title":"Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients","volume":"31","author":"Cotte","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0285","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","article-title":"Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of the NCI of Milan","volume":"32","author":"Raspagliesi","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0290","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/IGC.0b013e3181c50cde","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry","volume":"20","author":"Helm","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2013.09.024_b0295","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1245\/s10434-012-2510-4","article-title":"Cytoreductive surgery and intraperitoneal chemotherapy for persistent and recurrent advanced ovarian carcinoma: a multicenter prospective study of 246 patients","volume":"19","author":"Bakrin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0300","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.surg.2004.11.007","article-title":"Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas","volume":"137","author":"Elias","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.ejca.2013.09.024_b0305","unstructured":"Elias D, David A, Sourrouille I, et al. Neuroendocrine carcinomas: optimal surgery of peritoneal metastases (and associated intra-abdominal metastases). Surgery, 2013 (in press) http:\/\/dx.doi.org\/10.106\/jsurg.2013.05.030."},{"key":"10.1016\/j.ejca.2013.09.024_b0310","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors in a tertiary referral center","volume":"36","author":"Norlen","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.ejca.2013.09.024_b0315","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1245\/s10434-010-1229-3","article-title":"Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy","volume":"18","author":"Munene","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0320","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","article-title":"Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"17","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0325","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/jso.22130","article-title":"Updates on the multimodality management of desmoplastic small round cell tumor. Review","volume":"105","author":"Kallianpur","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.09.024_b0330","first-page":"1069","article-title":"Peritoneal carcinomatosis from solid pseudopapillary neoplasm (Frantz\u2019s tumor) of the pancreas treated with HIPEC","volume":"32","author":"Honore","year":"2012","journal-title":"Anticancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491300899X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491300899X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T19:47:29Z","timestamp":1646855249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491300899X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S095980491300899X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.09.024","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2013.09.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}